{{Message}}

Utrecht, December 12, 2014

Mediq today announces that Jesper Boysen, Executive Vice President Nordics and Baltics, will be leaving the company and that Joergen Kelkjaer has been appointed as his successor.

Jesper Boysen joined Mediq in 2006 and has been EVP Nordics & Baltics since 2009. Jesper Boysen was responsible for six acquisitions and therefore played a significant role in building Mediq’s position in the healthcare market in the Nordics and Baltics. 

Joergen Kelkjaer is appointed as of 1 January as EVP Nordic & Baltics, joining the company with years of experience executing successful corporate strategies that drive growth. Joergen Kelkjaer has been Managing Director at Tjellesen Max Jenne (part of Celesio) since 2009. Prior to this Kelkjaer has held various management positions for among others Novo Nordisk, NNE Pharmaplan and Nomeco. Kelkjaer has the Danish nationality.

Arthur de Bok, CEO Mediq: “I’d like to thank Jesper for the many years of work that he has contributed to the company. Jesper built the successful foundation for our growth in the Nordics & Baltics. We wish him all the best. At the same time I’m happy Joergen joins the Executive Committee. I’m confident that with his extensive experience, we’re able to further strengthen our international position.”

Mediq supplies medical devices, pharmaceuticals and associated care in 14 countries.  The focus of Mediq is to strengthen its international position by driving growth autonomously as well as through acquisitions. Mediq has further intensified the search for acquisitions and therefore appointed Leah Bayer as Director Business Development and Mergers & Acquisitions. Bayer has the American nationality and worked for various companies, including Siemens AG, IBM Consulting Services, Bain & Company, and most recently Davita, a healthcare service provider.

Maarssen/Utrecht, December 09, 2014

Brocacef Groep and Mediq Pharmacies Nederland join forces to create strong pharmaceutical care proposition

New combination a leading player in Dutch pharmaceutical market in care and customer satisfaction
Dense network of pharmacies across the country
Entrepreneurship Brocacef joins with innovation power Mediq Pharmacies
Consumer benefits from good, accessible and affordable care 
Jointly accelerated development of innovative pharmaceutical care programs
The continuation of productive collaborations with healthcare insurers

Brocacef Groep NV (“Brocacef”) announces the intended acquisition of Mediq Pharmacies Nederland B.V. with the objective to become the leading integrated healthcare provider in The Netherlands. Brocacef aims, with the acquisition, to continue providing affordable care for all relevant customers. The transaction includes, besides the pharmacies and wholesale distribution of Mediq Pharmacies, also the divisions active in the delivery of medicines to hospitals and logistics services. 

The new combination is a leading player in the healthcare market with revenues of EUR 2.1 billion, a network of pharmacies with nationwide coverage, 5,300 employees and a complete offering of pharmaceutical products and services. The entrepreneurial Brocacef and innovative Mediq are highly complementary both geographically and in terms of their offering. Mediq Pharmacies has for instance broad experience in the successful operation of the pharmacist formula like the successful integrated pharmaceutical care program. The entrepreneurial Brocacef Groep achieved strong growth in previous years by meeting customer needs translating into a high customer appreciation.   

It is the intention that in due course all pharmacies will be branded BENU and that the services for business customers will continue under the name Brocacef. In the coming period a joint integration plan will be developed. 

Peter de Jong, Managing Director of Brocacef Groep, explains: “Brocacef and Mediq are highly complementary. The acquisition is a logical step with which Brocacef responds to market developments, with the aim to keep good care affordable and accessible. As a result of the economies of scale further investments are possible in the development of innovations. With pride I welcome the employees of Mediq Pharmacies Nederland. We are convinced that the customer will also benefit from this acquisition. This acquisition will deliver a health bonus.” 

Arthur de Bok, CEO Mediq: "At Mediq the two divisions Mediq Pharmacies Nederland and Mediq Direct & Institutional have different dynamics, activities and strategy. Mediq Direct & Institutioneel operates internationally, contrary to Mediq Pharmacies, and delivers medical devices and accompanying care in 14 countries. We have decided to focus within Mediq in further growing the position of Mediq Direct & Institutional and finding a new owner for Mediq Pharmacies. In the previous period Mediq has made a careful analysis taking into consideration the different interests and the future success of Pharmacies Netherlands. We are convinced that Mediq Pharmacies has found a good partner in Brocacef." 

The acquisition is subject to the approval of the competition authorities. The expectation is that the acquisition will be effected next year. The (central) works councils of both companies have been consulted. Also the labour unions have been informed about the intended acquisition. 

It has been agreed that financial details of the transaction will not be disclosed.

Utrecht, November 28, 2014

Mediq has appointed Niels Hower as Executive Vice President Sourcing. Starting December 1, Hower will be responsible for the overall purchasing activities, private label development and quality.

Before joining Mediq, Niels Hower was Director of Non-Food Purchasing at Kaufland. 
Hower has held various managerial positions for large retail companies such as Praktiker 
AG and the Metro Group. Hower is 41 years old and a German citizen.
Arthur de Bok, CEO Mediq: “We’re happy to have Niels come in and join the team to 
further build strategic partnerships with our suppliers and to continuously develop our 
product offerings to all our key stakeholders.”

Utrecht, November 20, 2014

Philips and Medisch Service Nederland, a Mediq business unit, announced a partnership agreement today for the delivery and maintenance of a broad portfolio of ultrasound equipment to GPs. Doctors will now be able to perform many common diagnostic procedures in their office, allowing them to provide their patients with more targeted treatment or refer them to a specialist.

As the quality, flexibility and cost effectiveness of ultrasound technology continue to improve, it is becoming an increasingly important part of diagnostic practices. The number of GPs who use ultrasound technology in their examinations is also increasing. They can use ultrasound for e.g. stomach, intestinal and liver examinations of their patients.

For Philips, this collaboration represents a new step in primary healthcare in the Netherlands. For more than 20 years, Medisch Service Nederland has been supplying medical consumables, instruments and equipment to GPs, midwives and other care providers. Together, the two organizations can provide the growing group of doctors who want to use ultrasound technology in their practices with professional service that encompasses the latest technologies, maintenance and training.

“We see a growing need among GPs for the use of medical imaging in their practice to increase the quality and efficiency of their services at a time when the demand for healthcare is rising significantly, and we need to find ways to provide every patient with targeted, quality care, both today and in the future,” says Henk Valk, General Manager of Philips Healthcare Benelux. “This partnership and the services we have developed enable us to optimally support doctors in providing those services.”

Since 2011, Medisch Service Nederland has been a part of Mediq, which collaborates internationally with healthcare professionals on initiatives to increase efficiency in healthcare. “Medisch Service Nederland has been a partner to GPs for more than 20 years. This collaboration with Philips now offers us the possibility to take Philips’ proven technology out of hospitals and into doctors’ offices,” says Ronald Hoozemans, Managing Director of Mediq Medeco and Medisch Service Nederland.

Philips and Medisch Service Nederland will be demonstrating various compact ultrasound systems at the NGH Conference “Dokteren doe je niet alleen” (Doctoring takes a team) on Friday, November 21, in the RAI in Amsterdam.

See for more information http://www.medischservice.nl/echografie

Utrecht, November 06, 2014

Mediq CombiCare’s new Scan App puts an end to completing time-consuming order and accountability forms for continence products. By using this handy app on a tablet it now takes urology and continence nurses only 90 seconds to order these medical aids and without any errors. Time and attention can now be spent on patients rather than on filling out forms by hand.

Mediq teams up with care professionals to develop initiatives for improving efficiency within the care sector. The Scan App is just one of its products that makes a difference.

Eveline de Ruijter, nurse at the Beatrix Hospital in Gorinchem The Netherlands, has used Mediq CombiCare’s Scan App for a while now and has enjoyed the benefits in her daily work. “I can complete forms much faster with the Scan App than by hand and it is easy to use. Immediately after I scan the QR code, the content of the medical aids package is displayed on the screen. The app also reduces the number of mistakes to zero: accountability forms are no longer returned, which in turn saves time and a lot of frustration! And, more importantly: I can now dedicate more time and attention to patients.”

30,000 patients
Every year more than 30,000 patients in the Netherlands are given a starter kit containing continence products upon being discharged from hospital. The kit contains essential medical aids, such as catheter items or absorbent continence aids. But it takes up a lot of the nurses’ time to order the items, complete accountability forms for healthcare insurers, and to check and deliver these starter kits. Time that is in short supply.

The Scan App is quick and easy to use. “Nurses in five hospitals are currently using the Scan App to their complete satisfaction,” says Bas Brookman, Mediq CombiCare product manager. “Mediq makes the tablet and the app available to nurses. The Scan App is not linked to the hospital’s IT system and can therefore be used wherever the nurse happens to be. We are continuously improving the app’s functionality and are investigating whether we can use the system for other medical aids in the hospital as well.”

Mediq CombiCare will present its latest version of the Scan App during the jubilee symposium on the occasion of the V&VN  Urology Nurses 15th anniversary on 21 November 2014 at the CineMec in Ede.
The Scan App is an example of how Mediq and care professionals aim to improve efficiency within the care sector. Mediq CombiCare is the market leader in ostomy and continence products and wound treatment products and has partnered hospitals and nurses for more than 15 years.

Utrecht, June 24, 2014

Mediq introduces a new organization structure to respond effectively to the rapid changes in the healthcare sector. Arthur de Bok, CEO, today announced the new composition of the Mediq Executive Committee.

Mediq is an important international player and strives to find the right balance between 
improving patient care and keeping healthcare affordable. This is also what our 
customers – patients, healthcare professionals and healthcare insurers – demand. The 
challenges we are facing require a focused international strategy: collaboration, faster 
growth of the company and focus on functional expertise. 
 
The new structure consists of: 
Country clusters: to bring Mediq closer to local markets and closer to our clients
Functional expertise: sourcing, supply chain management and standardizing Mediq’s international business processes
Mediq Pharmacies Netherlands
Human Resource Management 
The composition of the Management Board will remain unchanged: Arthur de Bok (CEO) and Hans Janssen (CFO)
 
Arthur de Bok, CEO: “With a highly motivated and professional team, I am convinced that 
this new structure contributes to better and affordable healthcare. By better supporting 
our local business units, they can focus even more on providing added value in 
healthcare. Improving quality of life by helping people to participate in society for as long 
as possible, that is what it is all about.” 
 
With effect from 1 July the Executive Committee of Mediq consists of: 
Arthur de Bok, CEO and Chairman of the Management Board.
Hans Janssen, CFO and member of the Management Board.
Marcel van den Broek, Executive Vice President Benelux, France and USA.
Jesper Boysen, Executive Vice President Nordics and Baltic States.
Bernd Uhlmann, Executive Vice President Germany, Switzerland and Hungary.
Jan Dekker, CEO Mediq Pharmacies Netherlands.
Peter Kleij, Group Director HR.
Tony Webster, Group Director Supply Chain Management.
Thie Watse Brouwer, Executive Vice President of Business Transformation. 
 
Bernd Uhlmann, Peter Kleij, Tony Webster and Jan Dekker are newly appointed 
members in the Executive Committee. They come from inside the company.

Utrecht, May 27, 2014

On June 1, 2014, Thie Watse Brouwer will take a seat on the Executive Board of Mediq, filling the new position of Executive Vice President of Business Transformation. He will focus on the further optimization and standardization of Mediq’s international business operations.

Brouwer joined Mediq in 2005 as operations director at OPG Groothandel, a warehousing unit. Among his other positions, he has also worked as CFO of Byram Healthcare, Mediq’s American business unit. His last job was as the general manager of Mediq Direct in the Netherlands.

“The healthcare world is in a state of constant flux and Mediq is a major international player,” says Arthur de Bok, Mediq CEO. “Mediq is capitalizing on that changing market by trying to find the right balance between premium-quality and affordable care. We can boost our efficiency by harmonizing our business processes. With his years of international experience working for Mediq, we are convinced that Thie Watse is the right person to accomplish this.”

Utrecht, April 23, 2014

With the completion of the sale of ACP Pharma in Poland per 14 April, Gerben Klein Nulent will be stepping down as a member of the Mediq Executive Board as of 1 May. Gerben Klein Nulent will continue to work with the management team of Mediq Pharmacies Netherlands as a consultant and, in this capacity, will continue to represent Mediq, among others, as chairman of ASKA (Association of Chain Pharmacies).

Gerben Klein Nulent: “For nearly 20 years, I have worked with great pleasure for Mediq. First as CEO Mediq Pharmacies Netherlands, later as CEO ACP Pharma in Poland and member of the Executive Board. The completion of the sale of our pharmacy and wholesale activities in Poland is a logical moment in time for me to step down. I am extremely proud to have been part of what is now the largest chain of pharmacies in the Netherlands from the very start, as well as the introduction of Mediq Apteka in Poland.” 

Rob ter Haar, Chairman of the Supervisory Board, comments: “The Supervisory Board and Executive Board are grateful to Gerben for his significant contribution these past years. He was partly responsible for enabling OPG to develop from a pharmaceutical wholesaler to a leading national chain of pharmacies, Mediq Pharmacies.”

Utrecht, March 21, 2014

The Supervisory Board announces the appointment of Arthur de Bok as the new CEO and Chairman of the Management Board of Mediq as of 1 April 2014. 

Arthur de Bok (1962) has extensive international experience and has held several executive positions at Goodyear Tire & Rubber Company and Procter & Gamble, most recently as President of Goodyear EMEA. 
 
Arthur de Bok will use his international business expertise to strengthen Mediq’s position as an international service provider in the healthcare market. 
 
Rob ter Haar, chairman of the Supervisory Board, said, “The Mediq Supervisory Board and management team are enthusiastic about Arthur de Bok taking up this position. The healthcare field is continually developing and Mediq is a key international player in it. We are convinced that Arthur, with his extensive experience, is the right person to help Mediq respond to this development and extend Mediq’s lead in this field.” 

Utrecht, January 30, 2014

Marc van Gelder, Chief Executive Officer (CEO) and Chairman of the Management Board, has announced today that, after nine years, he has decided to step down as CEO of Mediq. Van Gelder has taken this decision in good consultation with the Supervisory Board. 

Marc van Gelder: “After building Mediq over the past nine years into a leading international healthcare delivery company, this is for me a natural moment to hand over the leadership. 2013 was a good year for Mediq, as we successfully implemented the transition from a public to a private company. Mediq is now in a strong position. I am immensely proud to have led this company over the past nine years and to have had the opportunity to work with a great and committed Mediq team.” 
 
Rob ter Haar, Chairman of the Supervisory Board: “On behalf of the Supervisory Board we are grateful to Marc for his leadership during the last nine years. In this period Mediq developed from a Dutch pharmacy chain and pharmaceutical wholesale company (OPG) into an international homecare delivery company. Mediq has now achieved leading positions in the delivery of medical devices, pharmaceuticals and related care to patients and healthcare professionals in fifteen countries. Under Marc’s leadership Mediq also strengthened its position in the Dutch pharmacies market as “OPG” was rebranded to “Mediq”. By combining the strengths and cultures of all the individual companies it incorporated, the company was transformed by Marc into the leading healthcare player it is today.” 
 
Rob ter Haar will work closely together with Marc and the other members of the Executive Board to ensure a smooth transition of responsibilities to a new CEO. A search has been initiated for a successor. 

Mediq.com is using cookies

We use cookies to make Mediq websites easier to use, to deliver a personalised experience on our websites, and to better tailor our products, services and websites to your interests and needs.